JP2022546807A5 - - Google Patents
Info
- Publication number
- JP2022546807A5 JP2022546807A5 JP2022513249A JP2022513249A JP2022546807A5 JP 2022546807 A5 JP2022546807 A5 JP 2022546807A5 JP 2022513249 A JP2022513249 A JP 2022513249A JP 2022513249 A JP2022513249 A JP 2022513249A JP 2022546807 A5 JP2022546807 A5 JP 2022546807A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- independently
- aliphatic
- formula
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019903263 | 2019-09-04 | ||
| AU2019903263A AU2019903263A0 (en) | 2019-09-04 | Cancer treatment | |
| AU2019904863 | 2019-12-20 | ||
| AU2019904863A AU2019904863A0 (en) | 2019-12-20 | Cancer treatment (2) | |
| PCT/AU2020/050936 WO2021042174A1 (en) | 2019-09-04 | 2020-09-04 | Cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546807A JP2022546807A (ja) | 2022-11-09 |
| JP2022546807A5 true JP2022546807A5 (https=) | 2023-09-11 |
Family
ID=74851931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513249A Pending JP2022546807A (ja) | 2019-09-04 | 2020-09-04 | 癌の治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220347146A1 (https=) |
| EP (1) | EP4025203A4 (https=) |
| JP (1) | JP2022546807A (https=) |
| AU (1) | AU2020343725A1 (https=) |
| WO (1) | WO2021042174A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2618842B1 (en) | 2010-09-22 | 2019-04-24 | Ena Therapeutics Pty Ltd | Novel immunostimulatory method |
| AU2018391325B2 (en) | 2017-12-21 | 2024-07-11 | Axelia Oncology Pty Ltd | Optimised compounds |
| MX2021015961A (es) | 2019-06-26 | 2022-03-22 | Ena Respiratory Pty Ltd | Moleculas novedosas. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101151280A (zh) * | 2005-02-08 | 2008-03-26 | 昆士兰医学研究学院委员会 | 免疫原性分子 |
| GB0907989D0 (en) * | 2009-05-08 | 2009-06-24 | Hybrid Systems Ltd | Multivalent adjuvant display |
| EP2618842B1 (en) * | 2010-09-22 | 2019-04-24 | Ena Therapeutics Pty Ltd | Novel immunostimulatory method |
| CN113876945A (zh) * | 2011-10-06 | 2022-01-04 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
| US20170274068A1 (en) * | 2014-09-12 | 2017-09-28 | The University Of Melbourne | Immunological reagent |
| EP3328418A1 (en) * | 2015-07-29 | 2018-06-06 | Novartis AG | Combination therapies comprising antibody molecules to pd-1 |
| CN110461351B (zh) * | 2017-03-31 | 2024-03-26 | 艾娜呼吸私人有限公司 | 用tlr2激动剂治疗呼吸道感染 |
| AU2018391325B2 (en) * | 2017-12-21 | 2024-07-11 | Axelia Oncology Pty Ltd | Optimised compounds |
| AU2020340468A1 (en) * | 2019-09-04 | 2022-03-24 | Axelia Oncology Pty Ltd | Cancer immunotherapy |
-
2020
- 2020-09-04 US US17/640,714 patent/US20220347146A1/en active Pending
- 2020-09-04 AU AU2020343725A patent/AU2020343725A1/en active Pending
- 2020-09-04 EP EP20859699.9A patent/EP4025203A4/en active Pending
- 2020-09-04 JP JP2022513249A patent/JP2022546807A/ja active Pending
- 2020-09-04 WO PCT/AU2020/050936 patent/WO2021042174A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025160318A5 (https=) | ||
| JP2022546807A5 (https=) | ||
| JP2025160317A5 (https=) | ||
| TWI250163B (en) | Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts | |
| JP2022546806A5 (https=) | ||
| JP2024522174A5 (https=) | ||
| JP2023520047A5 (https=) | ||
| JP2019043957A5 (https=) | ||
| JP2018138577A5 (https=) | ||
| JP2021152063A5 (https=) | ||
| CN109843872A (zh) | 作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物 | |
| JP2020507589A5 (https=) | ||
| JP2011524422A5 (https=) | ||
| JP2020508985A5 (https=) | ||
| CN102317257A (zh) | 制备不对称双(缩氨基硫脲)的方法 | |
| TW442452B (en) | Serine protease inhibitors having an alkynylamino side chain | |
| JP2015512413A5 (https=) | ||
| JP2022541747A5 (https=) | ||
| TW201609745A (zh) | 抗病毒化合物的固態形式 | |
| JP2023538524A5 (https=) | ||
| JP2022539091A5 (https=) | ||
| JP2024510939A5 (https=) | ||
| JP2017518363A5 (https=) | ||
| JP2023552490A5 (https=) | ||
| HU195830B (en) | Process for preparing tumor inhibiting (1-benzyl-ethylene-diamine)-platinum(ii) complexes and pharmaceutical compositions containing such compounds |